Do D-dimer levels during and after anticoagulation withdrawal differ between patients treated with DOACs versus warfarin for venous thromboembolism?
D-dimer levels behave differently upon withdrawal of DOACs compared to warfarin, suggesting the need to reassess its utility as a predictor of recurrent VTE in DOAC-treated patients.
D-dimer levels during and after stopping an anticoagulant treatment for a venous thromboembolism episode differ between patients treated with a DOAC than in those treated with warfarin. Specifically designed prospective studies are warranted to reassess the use of D-dimer as predictor of the risk of recurrent venous thromboembolism in patients treated with DOACs.
Legnani et al. (Tue,) studied this question.